Oyster Point Pharma
Commercial-stage biopharmaceutical company focused on pharmaceutical therapies to treat ophthalmic diseases.
Princeton, United States
88 employees
Post-IPO Equity
Total: $235.80M
Biopharma, Health Care +1
General Information
Princeton, United States
BounceWatch is an independent company data service, not affiliated with Oyster Point Pharma. To contact Oyster Point Pharma, visit oysterpointrx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Oyster Point Pharma compare?
A PDF of Oyster Point Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Oyster Point Pharma soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Oyster Point Pharma on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biopharma
About Oyster Point Pharma
Business keywords: biopharmaceutical company, ophthalmic diseases, clinical-stage, pharmaceutical therapies, ocular surface diseases, OC-01, nicotinic acetylcholine receptor, dry eye disease, tear film homeostasis, Lacrimal Functional Unit, pharmaceutical development, innovative treatments, nasal spray, medical research, healthcare industry
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | $120.80M | - |
|
12 May 2020 |
| Series B | $93.00M | 5 |
|
26 Feb 2019 |
| Series A | $22.00M | 2 |
|
07 Nov 2017 |
Oyster Point Pharma Alternatives & Competitors
View All Alternatives
We are a late-stage biopharmaceutical company focused on developing & commercializing products to tr...
A clinical-stage immunology focused biopharmaceutical company.
KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegenerative di...
FAQ About Oyster Point Pharma
Source: BounceWatch company record for Oyster Point Pharma, https://bouncewatch.com/company/oyster-point-pharma, updated 30 December 2024. When citing, please name BounceWatch and link this page.
